TY - JOUR T1 - Modeling infection dynamics and mitigation strategies to support K-6 in-person instruction during the COVID-19 pandemic JF - medRxiv DO - 10.1101/2021.02.27.21252535 SP - 2021.02.27.21252535 AU - Douglas E. Morrison AU - Roch Nianogo AU - Vladimir Manuel AU - Onyebuchi A. Arah AU - Nathaniel Anderson AU - Tony Kuo AU - Moira Inkelas Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/01/2021.02.27.21252535.abstract N2 - Objective To support safer in-person K-6 instruction during the coronavirus disease 2019 (COVID- 19) pandemic by providing public health authorities and school districts with a practical model of transmission dynamics and mitigation strategies.Methods We developed an agent-based model of infection dynamics and preventive mitigation strategies such as distancing, health behaviors, surveillance and symptomatic testing, daily symptom and exposure screening, quarantine policies, and vaccination. The model parameters can be updated as the science evolves and are adjustable via an online user interface, enabling users to explore the effects of interventions on outcomes of interest to states and localities, under a variety of plausible epidemiological and policy assumptions.Results Under default assumptions, secondary infection rates and school attendance are substantially affected by surveillance testing protocols, vaccination rates, class sizes, and effectiveness of safety education.Conclusions Our model helps policymakers consider how mitigation options and the dynamics of school infection risks affect outcomes of interest. The model’s parameters can be immediately updated in response to changes in epidemiological conditions, science of COVID-19 transmission dynamics, testing and vaccination resources, and reliability of mitigation strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by NIH National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant Number UL1TR001881 and UCLA CTSI Grant Number TL1TR001883. Dr. Arah was also supported by the Karen Toffler Charitable Trust. The views expressed are those of the authors and not necessarily those of the funding agencies.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No human subjects were involved in this research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo original data was used in this manuscript. https://agent-based-models.shinyapps.io/RegionalCOVIDSchoolSimulation/ ER -